_MEMBER_MyList,_LogP_MyList,GO,_PATTERN_,_RANK_,GiniIndex,Category,CategoryID,Description,PARENT_GO,LogP,Enrichment,Z-score,#TotalGeneInLibrary,#GeneInGO,#GeneInHitList,#GeneInGOAndHitList,%InGO,STDV %InGO,GeneID,Hits,Log(q-value),EvidenceCutoff
1,-5,C4733095,M1,1,0,DisGeNET,35,HER2-negative breast cancer,,-5,29,10,30286,160,26,4,15,7.1,3561|4605|5610|11004,IL2RG|MYBL2|EIF2AK2|KIF2C,-1.3,0
1,-4.3,C1997217,M1,1,0,DisGeNET,35,Low grade glioma,,-4.3,41,11,30286,85,26,3,12,6.3,2014|3418|4605,EMP3|IDH2|MYBL2,-0.79,0
1,-3.4,C0008074,M1,1,0,DisGeNET,35,"Child Development Disorders, Pervasive",,-3.4,21,7.5,30286,168,26,3,12,6.3,9638|11118|11120,FEZ1|BTN3A2|BTN2A1,-0.23,0
1,-3.3,C0023530,M1,1,0,DisGeNET,35,Leukopenia,,-3.3,11,5.9,30286,440,26,4,15,7.1,2030|4522|9837|10443,SLC29A1|MTHFD1|GINS1|N4BP2L2,-0.2,0
1,-3.1,C0079772,M1,1,0,DisGeNET,35,T-Cell Lymphoma,,-3.1,9.6,5.6,30286,485,26,4,15,7.1,916|3418|3561|5610,CD3E|IDH2|IL2RG|EIF2AK2,-0.077,0
1,-3,C0282612,M1,1,0,DisGeNET,35,Prostatic Intraepithelial Neoplasias,,-3,15,6.3,30286,230,26,3,12,6.3,4502|11010|22936,MT2A|GLIPR1|ELL2,0,0
1,-3,C0024312,M1,1,0,DisGeNET,35,Lymphopenia,,-3,15,6.2,30286,239,26,3,12,6.3,1503|3561|4522,CTPS1|IL2RG|MTHFD1,0,0
1,-2.8,C4086152,M1,1,0,DisGeNET,35,Childhood Astrocytoma,,-2.8,7.6,4.8,30286,615,26,4,15,7.1,901|3418|9928|11010,CCNG2|IDH2|KIF14|GLIPR1,0,0
1,-2.7,C0085110,M1,1,0,DisGeNET,35,Severe Combined Immunodeficiency,,-2.7,12,5.6,30286,284,26,3,12,6.3,916|3561|4522,CD3E|IL2RG|MTHFD1,0,0
1,-2.7,C0007138,M1,1,0,DisGeNET,35,"Carcinoma, Transitional Cell",,-2.7,7.5,4.8,30286,622,26,4,15,7.1,916|2014|3418|9446,CD3E|EMP3|IDH2|GSTO1,0,0
1,-2.7,C1960398,M1,1,0,DisGeNET,35,HER2-positive carcinoma of breast,,-2.7,12,5.6,30286,288,26,3,12,6.3,3561|5610|11004,IL2RG|EIF2AK2|KIF2C,0,0
1,-2.7,C0023465,M1,1,0,DisGeNET,35,Acute monocytic leukemia,,-2.7,7.4,4.7,30286,633,26,4,15,7.1,3418|3561|5610|11010,IDH2|IL2RG|EIF2AK2|GLIPR1,0,0
1,-2.7,C0085669,M1,1,0,DisGeNET,35,Acute leukemia,,-2.7,7.3,4.7,30286,639,26,4,15,7.1,1503|3418|4522|5610,CTPS1|IDH2|MTHFD1|EIF2AK2,0,0
1,-2.6,C1861403,M1,1,0,DisGeNET,35,Variable expressivity,,-2.6,11,5.2,30286,319,26,3,12,6.3,916|2760|9928,CD3E|GM2A|KIF14,0,0
1,-2.6,C3900098,M1,1,0,DisGeNET,35,Adult Myelodysplastic Syndrome,,-2.6,11,5.1,30286,332,26,3,12,6.3,2030|3418|11010,SLC29A1|IDH2|GLIPR1,0,0
1,-2.5,C2347761,M1,1,0,DisGeNET,35,Childhood Myelodysplastic Syndrome,,-2.5,10,5.1,30286,335,26,3,12,6.3,2030|3418|11010,SLC29A1|IDH2|GLIPR1,0,0
1,-2.4,C0003504,M1,1,0,DisGeNET,35,Aortic Valve Insufficiency,,-2.4,9.3,4.7,30286,377,26,3,12,6.3,916|2030|3418,CD3E|SLC29A1|IDH2,0,0
1,-2.4,C0035078,M1,1,0,DisGeNET,35,Kidney Failure,,-2.4,9.2,4.7,30286,378,26,3,12,6.3,3418|4502|5973,IDH2|MT2A|RENBP,0,0
1,-2.4,C0027947,M1,1,0,DisGeNET,35,Neutropenia,,-2.4,9,4.6,30286,389,26,3,12,6.3,2030|9837|10443,SLC29A1|GINS1|N4BP2L2,0,0
1,-2.2,C0542476,M1,1,0,DisGeNET,35,Forgetful,,-2.2,8.1,4.4,30286,429,26,3,12,6.3,2030|5610|9446,SLC29A1|EIF2AK2|GSTO1,0,0
1,-2.2,C0085580,M1,1,0,DisGeNET,35,Essential Hypertension,,-2.2,7.9,4.3,30286,445,26,3,12,6.3,4522|5973|9446,MTHFD1|RENBP|GSTO1,0,0
1,-2.2,C2145472,M1,1,0,DisGeNET,35,Urothelial Carcinoma,,-2.2,7.8,4.3,30286,448,26,3,12,6.3,2014|3418|9446,EMP3|IDH2|GSTO1,0,0
1,-2.1,C0032927,M1,1,0,DisGeNET,35,Precancerous Conditions,,-2.1,7.4,4.1,30286,471,26,3,12,6.3,3418|4605|9446,IDH2|MYBL2|GSTO1,0,0
1,-2.1,C0242339,M1,1,0,DisGeNET,35,Dyslipidemias,,-2.1,7.4,4.1,30286,471,26,3,12,6.3,3418|5973|11120,IDH2|RENBP|BTN2A1,0,0
1,-2,C0023493,M1,1,0,DisGeNET,35,Adult T-Cell Lymphoma/Leukemia,,-2,6.5,3.8,30286,540,26,3,12,6.3,3561|5973|9446,IL2RG|RENBP|GSTO1,0,0
1,-1.9,C0001973,M1,1,0,DisGeNET,35,"Alcoholic Intoxication, Chronic",,-1.9,6.1,3.6,30286,577,26,3,12,6.3,2030|2760|6303,SLC29A1|GM2A|SAT1,0,0
1,-1.8,C0020459,M1,1,0,DisGeNET,35,Hyperinsulinism,,-1.8,5.6,3.4,30286,620,26,3,12,6.3,901|4502|5973,CCNG2|MT2A|RENBP,0,0
1,-1.8,C0011991,M1,1,0,DisGeNET,35,Diarrhea,,-1.8,5.5,3.4,30286,631,26,3,12,6.3,3561|6303|9837,IL2RG|SAT1|GINS1,0,0
1,-1.8,C0019348,M1,1,0,DisGeNET,35,Herpes Simplex Infections,,-1.8,5.4,3.3,30286,645,26,3,12,6.3,2030|4605|5610,SLC29A1|MYBL2|EIF2AK2,0,0
1,-1.8,C0085207,M1,1,0,DisGeNET,35,Gestational Diabetes,,-1.8,5.4,3.3,30286,649,26,3,12,6.3,901|2030|6303,CCNG2|SLC29A1|SAT1,0,0
1,-1.7,C4521042,M1,1,0,DisGeNET,35,Complete Trisomy 21 Syndrome,,-1.7,5.2,3.2,30286,668,26,3,12,6.3,4502|4522|5973,MT2A|MTHFD1|RENBP,0,0
1,-1.7,C0242383,M1,1,0,DisGeNET,35,Age related macular degeneration,,-1.7,5.1,3.2,30286,685,26,3,12,6.3,3561|4502|5973,IL2RG|MT2A|RENBP,0,0
1,-1.7,C4551686,M1,1,0,DisGeNET,35,Malignant neoplasm of soft tissue,,-1.7,5,3.1,30286,699,26,3,12,6.3,916|3418|3561,CD3E|IDH2|IL2RG,0,0
1,-1.7,C0024115,M1,1,0,DisGeNET,35,Lung diseases,,-1.7,5,3.1,30286,700,26,3,12,6.3,2030|5973|9446,SLC29A1|RENBP|GSTO1,0,0
1,-1.7,C0038013,M1,1,0,DisGeNET,35,Ankylosing spondylitis,,-1.7,4.9,3.1,30286,710,26,3,12,6.3,3561|6303|9837,IL2RG|SAT1|GINS1,0,0
1,-1.6,C0024305,M1,1,0,DisGeNET,35,"Lymphoma, Non-Hodgkin",,-1.6,4.8,3,30286,733,26,3,12,6.3,3418|3561|4522,IDH2|IL2RG|MTHFD1,0,0
1,-1.6,C0521158,M1,1,0,DisGeNET,35,Recurrent tumor,,-1.6,4.8,3,30286,735,26,3,12,6.3,3418|9446|11010,IDH2|GSTO1|GLIPR1,0,0
1,-1.6,C0233794,M1,1,0,DisGeNET,35,Memory impairment,,-1.6,4.6,2.9,30286,763,26,3,12,6.3,2030|5610|9446,SLC29A1|EIF2AK2|GSTO1,0,0
1,-1.6,C0013080,M1,1,0,DisGeNET,35,Down Syndrome,,-1.6,4.6,2.9,30286,765,26,3,12,6.3,4502|4522|5973,MT2A|MTHFD1|RENBP,0,0
